Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVODOPA vs LEVOMILNACIPRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVODOPA vs LEVOMILNACIPRAN: Safety Overview

Metric LEVODOPA LEVOMILNACIPRAN
Total FAERS Reports 6,610 1,378
Deaths Reported 546 382
Death Rate 8.3% 27.7%
Hospitalizations 729 378
Average Patient Age 69.3 yrs 46.4 yrs
% Female Patients 42.9% 80.2%
FDA Approval Date Approved Prior to Jan 1, 1982 Feb 4, 2019
Manufacturer Deseret Biologicals, Inc. Allergan, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription